Perry R R, Nieman L K, Cutler G B, Chrousos G P, Loriaux D L, Doppman J L, Travis W D, Norton J A
Surgical Metabolism Section, National Cancer Institute, Bethesda, MD 20892.
Ann Surg. 1989 Jul;210(1):59-68. doi: 10.1097/00000658-198907000-00010.
Cushing's syndrome is rare with only 20% of patients having a primary adrenal cause of hypercortisolism. We have developed a strategy to evaluate patients with suspected Cushing's syndrome and to localize the pathologic condition responsible for the hypercortisolism. This report reviews the last 11 consecutive patients who had a primary adrenal cause of hypercortisolism. Each patient had elevated 24-hour urine free cortisol and 17-hydroxycorticosteroid excretion consistent with hypercortisolism. All but one patient had undetectable plasma ACTH levels. No patient suppressed urinary steroid levels with high-dose dexamethasone and only one patient increased plasma ACTH or cortisol levels with oCRH, findings that were consistent with a pituitary-independent form of hypercortisolism. No patient had a pituitary tumor detected by computed tomography or magnetic resonance imaging, and eight patients had adrenal tumors accurately imaged. MRI of the adrenal glands correctly diagnosed adenoma in 5 of 6 patients with adenomas, carcinoma in 1 patient, and ACTH-producing pheochromocytoma in 1 patient. One tumor classified as carcinoma by MRI appeared on pathologic examination to be an adenoma. Three patients underwent petrosal sinus sampling for measurement of ACTH before and after oCRH administration, and each had petrosal sinus ACTH levels equal to peripheral levels, consistent with a primary adrenal cause of hypercortisolism. Two of these patients had typical bilateral pigmented micronodular adrenocortical disease and the third patient had macronodular adrenocortical hyperplasia. Each of the 11 patients was cured of hypercortisolism by unilateral or bilateral adrenalectomy and no patient has developed recurrent disease during the 7 to 29 month follow-up period. New modalities including the ovine CRH test, MRI, and petrosal sinus sampling have improved the evaluation of certain patients with Cushing's syndrome.
库欣综合征较为罕见,仅20%的患者高皮质醇血症的病因是原发性肾上腺疾病。我们制定了一项策略,用于评估疑似库欣综合征的患者,并确定导致高皮质醇血症的病理状况。本报告回顾了连续11例原发性肾上腺疾病导致高皮质醇血症的患者。每位患者的24小时尿游离皮质醇和17-羟皮质类固醇排泄量升高,符合高皮质醇血症表现。除1例患者外,所有患者的血浆促肾上腺皮质激素(ACTH)水平均检测不到。所有患者的尿类固醇水平均未被大剂量地塞米松抑制,只有1例患者使用促肾上腺皮质激素释放激素(oCRH)后血浆ACTH或皮质醇水平升高,这些结果与非垂体性高皮质醇血症相符。计算机断层扫描(CT)或磁共振成像(MRI)均未发现垂体肿瘤,8例患者的肾上腺肿瘤得到了准确成像。肾上腺MRI正确诊断出6例腺瘤患者中的5例为腺瘤,1例为癌,1例为分泌ACTH的嗜铬细胞瘤。1例MRI诊断为癌的肿瘤经病理检查为腺瘤。3例患者在注射oCRH前后接受了岩下窦采血以测量ACTH,每位患者的岩下窦ACTH水平均与外周水平相等,符合高皮质醇血症的原发性肾上腺病因。其中2例患者患有典型的双侧色素沉着性微结节性肾上腺皮质疾病,第3例患者患有大结节性肾上腺皮质增生。11例患者均通过单侧或双侧肾上腺切除术治愈了高皮质醇血症,在7至29个月的随访期内,无患者出现疾病复发。包括绵羊CRH试验、MRI和岩下窦采血在内的新方法改善了对某些库欣综合征患者的评估。